Drug Type CAR-T |
Synonyms Anti-CLL1 Chimeric Antigen Receptor Engineered T-Cell(The First Affiliated Hospital of Soochow University) |
Target |
Mechanism CLL-1 modulators(C-Type lectin domain family 12 member A modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Relapsing acute myeloid leukemia | Phase 2 | CN | 01 Jul 2017 |